PFIZER COULD LOSE BILLIONS IN LIPITOR PATENT RULING

A federal appeals court dealt Pfizer Inc. a legal setback Wednesday when it issued a ruling that threatens to cut 15 months from the patent life of its popular cholesterol drug Lipitor, the world's biggest-selling medicine.
CNN Money